Genetic products maker Affymetrix Inc (NASDAQ:AFFX) recently announced that it has entered into a global distribution agreement with ScreenCell, a medical devices company, which specializes in isolating rare circulatory cells. Under the agreement, Affymetrix will be the sole distributor of ScreenCell’s Circulatory Tumour Cells (“CTC”) Technology, to be used only for research purposes. Affymetrix has launched the QuantiGene ViewRNA CTC Platform, which combines ScreenCell’s unique isolation … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards
Learn How ›
Wednesday, September 21, 2011
Marriott Marquis, New York
Get quotes, news and more market data ›
Discover how the financial industry is sparking economic growth and job creation in communities like yours.
Dedicated to fostering knowledge and understanding of the financial markets for individuals of all backgrounds.
Meet with your colleagues in Professional Societies to share best practices, attend educational seminars and engage in peer-to-peer networking.